Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

350
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
350
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

307
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
307
Cancer Survival Analysis01:21

Cancer Survival Analysis

481
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
Actuarial Approach01:20

Actuarial Approach

157
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
157
Survival Tree01:19

Survival Tree

183
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
183
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

218
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
218

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variable selection for estimating optimal treatment regimes with multiple treatments.

Scientific reports·2026
Same author

Rejoinder to Letter to the Editors "Comments on 'Statistical inference on change points in generalized semiparametric segmented models' by Yang et al. (2025)" by Vito M.R. Muggeo.

Biometrics·2025
Same author

Statistical methods for composite analysis of recurrent and terminal events in clinical trials.

Lifetime data analysis·2025
Same author

Optimal treatment regimes in the presence of a cure fraction.

Statistical methods in medical research·2025
Same author

Performance and Mechanism of Brucite/g-C<sub>3</sub>N<sub>4</sub> Catalyst-Activated Peroxymonosulfate for Rapid Degradation of Methylene Blue.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Statistical inference on change points in generalized semiparametric segmented models.

Biometrics·2025

Related Experiment Video

Updated: Oct 19, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Robust method for optimal treatment decision making based on survival data.

Yuexin Fang1, Baqun Zhang2, Min Zhang3

  • 1Department of Mathematics, Shanghai Normal University, Shanghai, P.R. China.

Statistics in Medicine
|September 22, 2021
PubMed
Summary
This summary is machine-generated.

We developed methods to find the best treatment for individuals using survival data. Our approach estimates optimal treatment decision rules by analyzing treatment contrasts, improving personalized medicine strategies.

Keywords:
augmented inverse probability weighted estimatordecision ruledoubly robustoptimal treatment regimesubgroup identificationvariable selection

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Related Experiment Videos

Last Updated: Oct 19, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Personalized Medicine

Background:

  • Treatment effect heterogeneity necessitates individualized treatment strategies.
  • Optimal treatment decision rules aim to match the best treatment to patient characteristics.
  • Survival data analysis is crucial for many clinical outcomes.

Purpose of the Study:

  • To develop and evaluate novel methods for estimating optimal treatment decision rules using survival data.
  • To propose a flexible semiparametric accelerated failure time model for treatment contrast estimation.
  • To introduce robust estimators and novel loss functions for identifying individualized treatment effects.

Main Methods:

  • Utilized a semiparametric accelerated failure time model focusing on parameterized treatment contrasts.
  • Employed an augmented inverse probability weighted estimator (AIPWE) for robust estimation of individual treatment contrasts.
  • Developed two novel loss functions based on treatment contrasts to estimate the optimal decision rule, accounting for censoring.
  • Incorporated a penalty term for variable selection relevant to treatment decision-making.

Main Results:

  • The proposed methods demonstrated robust performance in simulation studies compared to existing approaches.
  • The AIPWE provided reliable estimates of individual treatment contrasts.
  • The novel loss functions effectively determined the optimal treatment rule.
  • Variable selection enhanced the performance of treatment decision rules.

Conclusions:

  • The developed methods provide a flexible and robust framework for estimating optimal treatment decision rules in the presence of survival endpoints.
  • The approach effectively handles treatment effect heterogeneity and censoring.
  • Application to the ACTG 175 trial demonstrates practical utility in identifying personalized treatment strategies for HIV-infected patients.